Source: Annual Congress 2003 - Biology of COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Gross, J. Soja, M. Duplaga, K. Nagraba, A. Gielicz, J. Radwan, K. Sladek (Krakow, Poland). The study of bronchospastic eicosanoids levels in asthma and COPD. Eur Respir J 2003; 22: Suppl. 45, 2882

Member's Comments

No comment yet.

Related content which might interest you: Erdosteine affects eicosanoid production in asthma and COPD Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Effects of roflumilast on exhaled NO, airway hyperresponsiveness, and inflammatory markers in patients with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Inhibiting effect of influenza vaccinations on serum eotaxin level in patients with allergic bronchial asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 134s Year: 2004 Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation Year: 2006 IL-33 in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 The association between airway hyperresponsiveness to mannitol and T2 inflammatory markers in asthma versus COPD Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007 Smoking effect on airways inflammation in asthma and COPD: relationship with airways reversibility and hyperresponsiveness Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Small airways and hyperresponsiveness in asthma and COPD Source: International Congress 2017 – Sadoul Lecture: "Airway hyperresponsiveness: the riddle of asthma and COPD" and related topics Year: 2017 Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 eNO, ECP and bronchial hyperresponsiveness in mild asthmatic children out of therapy Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005 JAK/STATs in asthma and COPD Source: Annual Congress 2004 - Transcription factors in airway disease Year: 2004 Are inflammatory phenotypes in children with severe asthma stable? Source: Annual Congress 2007 - Pathophysiology of childhood asthma: new insights Year: 2007 Characteristics and mechanisms of bronchial hyper-responsiveness in symptomatic subjects with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 209s Year: 2003 Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008